Combined approaches for targeting the dipeptidyl peptidase-IV (DPP-IV) enzyme: development of hypoglycaemic chemometric model, nanoformulation and in vitro studies using natural compound(s)

Dipeptidyl peptidase-IV (DPP-IV) is a crucial enzyme in metabolism management. Several natural compounds have been identified for the management of diabetes by inhibiting the DPP-IV enzyme, but they either express inadequate inhibition or lack a mechanistic approach. In the present studies, the chemometric model (MLR) was developed using natural compounds, and the compound with the most influential descriptor was selected for the preparation of microemulsion to counter the pharmaceutical challenges. The chemometric model resulted in caffeic acid (CA). The developed microemulsion (CAME) was characterised for globule size, zeta potential and polydispersity index with the respective values of 87.8 nm, 0.13 mV and 0.25. The spherical shape of MEs was confirmed by transmission electron microscopy (TEM). The drug released study for the prepared formulation was nearly 12% of CA in 0.1 N HCl for 2 h, 22.1% at pH 6.8 in the next 4 h. In pharmacokinetic studies, the bioavailability of CAME was increased fourfold compared to plain CA. The IC50 was 81.4 and 36.3 μM, respectively, for CA and CAME against the DPP-IV enzyme. Thus, these novel MEs could be promising in targeting the membrane-anchored DPP-IV enzyme by inhibiting the enzyme and enhanced oral bioavailability, warranting future in vivo pharmacodynamic studies to establish its therapeutic efficacy.

Authors

Institutions

Publication Details

Journal
Journal of Experimental Nanoscience
Published
2026-11-12
DOI
https://doi.org/10.1080/17458080.2026.2758300
Primary Topic
Natural Antidiabetic Agents Studies
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Combined approaches for targeting the dipeptidyl peptidase-IV (DPP-IV) enzyme: development of hypoglycaemic chemometric model, nanoformulation and in vitro studies using natural compound(s)

Kaisar Raza, Suresh Kumar Dev, Muhammad Wahajuddin, Rakesh Kumar Paul
Journal of Experimental Nanoscience
Natural Antidiabetic Agents Studies
article

Combined approaches for targeting the dipeptidyl peptidase-IV (DPP-IV) enzyme: development of hypoglycaemic chemometric model, nanoformulation and in vitro studies using natural compound(s)

Kaisar Raza, Suresh Kumar Dev, Muhammad Wahajuddin, Rakesh Kumar Paul
article en

Abstract

Dipeptidyl peptidase-IV (DPP-IV) is a crucial enzyme in metabolism management. Several natural compounds have been identified for the management of diabetes by inhibiting the DPP-IV enzyme, but they either express inadequate inhibition or lack a mechanistic approach. In the present studies, the chemometric model (MLR) was developed using natural compounds, and the compound with the most influential descriptor was selected for the preparation of microemulsion to counter the pharmaceutical challenges. The chemometric model resulted in caffeic acid (CA). The developed microemulsion (CAME) was characterised for globule size, zeta potential and polydispersity index with the respective values of 87.8 nm, 0.13 mV and 0.25. The spherical shape of MEs was confirmed by transmission electron microscopy (TEM). The drug released study for the prepared formulation was nearly 12% of CA in 0.1 N HCl for 2 h, 22.1% at pH 6.8 in the next 4 h. In pharmacokinetic studies, the bioavailability of CAME was increased fourfold compared to plain CA. The IC50 was 81.4 and 36.3 μM, respectively, for CA and CAME against the DPP-IV enzyme. Thus, these novel MEs could be promising in targeting the membrane-anchored DPP-IV enzyme by inhibiting the enzyme and enhanced oral bioavailability, warranting future in vivo pharmacodynamic studies to establish its therapeutic efficacy.

Journal of Experimental NanoscienceVol. 22(1)
University of Bradford (GB), Sri Venkateswara University (IN), Central University of Rajasthan (IN)
Indian Council of Medical Research, Indian Institute of Technology Kharagpur, Scheme for Promotion of Academic and Research Collaboration, Department of Health Research, India
Good health and well-being
Natural Antidiabetic Agents Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon